Israel's EndyMed a top stock on FDA wrinkle treatment approval

By Tova Cohen CAESAREA, Israel (Reuters) - One of Israel's best performing stocks in the last year isn't a cybersecurity start-up or a high-tech chipmaker but a firm whose products promise to reduce wrinkles and treat acne. Shares in EndyMed, which makes devices that use radio waves to rejuvenate skin, have surged 90 percent in the past year, with demand soaring following approval by the U.S. Food and Drug Administration (FDA) for its latest product. So far in 2015, the shares are up 49 percent, against a 5.7 percent rise in Tel Aviv's biomedical index, which includes biotech, medical device and life sciences companies.



via Health News Headlines - Yahoo News http://ift.tt/1Avow0j